JP2016520585A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016520585A5 JP2016520585A5 JP2016512879A JP2016512879A JP2016520585A5 JP 2016520585 A5 JP2016520585 A5 JP 2016520585A5 JP 2016512879 A JP2016512879 A JP 2016512879A JP 2016512879 A JP2016512879 A JP 2016512879A JP 2016520585 A5 JP2016520585 A5 JP 2016520585A5
- Authority
- JP
- Japan
- Prior art keywords
- molecule according
- collagen molecule
- chondroitin sulfate
- collagen
- pxg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000008186 Collagen Human genes 0.000 claims description 25
- 108010035532 Collagen Proteins 0.000 claims description 25
- 229920001436 collagen Polymers 0.000 claims description 25
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical group FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 claims description 14
- 229920001287 Chondroitin sulfate Polymers 0.000 claims description 13
- 229940059329 chondroitin sulfate Drugs 0.000 claims description 13
- 229920002683 Glycosaminoglycan Polymers 0.000 claims description 5
- 150000001413 amino acids Chemical class 0.000 claims description 5
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical group OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 2
- 229920000045 Dermatan sulfate Chemical group 0.000 claims description 2
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims description 2
- 229920002971 Heparan sulfate Chemical group 0.000 claims description 2
- 229920000288 Keratan sulfate Chemical group 0.000 claims description 2
- 150000003862 amino acid derivatives Chemical class 0.000 claims description 2
- 229910052799 carbon Inorganic materials 0.000 claims description 2
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical class CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 claims description 2
- AVJBPWGFOQAPRH-FWMKGIEWSA-L dermatan sulfate Chemical group CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS([O-])(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C([O-])=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-L 0.000 claims description 2
- 229940051593 dermatan sulfate Drugs 0.000 claims description 2
- 229920000669 heparin Chemical group 0.000 claims description 2
- 229960002897 heparin Drugs 0.000 claims description 2
- 229920002674 hyaluronan Chemical group 0.000 claims description 2
- KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical group CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 claims description 2
- 229940099552 hyaluronan Drugs 0.000 claims description 2
- KXCLCNHUUKTANI-RBIYJLQWSA-N keratan Chemical group CC(=O)N[C@@H]1[C@@H](O)C[C@@H](COS(O)(=O)=O)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H]([C@@H](COS(O)(=O)=O)O[C@@H](O)[C@@H]3O)O)[C@H](NC(C)=O)[C@H]2O)COS(O)(=O)=O)O[C@H](COS(O)(=O)=O)[C@@H]1O KXCLCNHUUKTANI-RBIYJLQWSA-N 0.000 claims description 2
- 238000005259 measurement Methods 0.000 claims description 2
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical group O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 claims 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 claims 1
- 239000012620 biological material Substances 0.000 claims 1
- 150000007942 carboxylates Chemical class 0.000 claims 1
- DZRJLJPPUJADOO-UHFFFAOYSA-N chaetomin Natural products CN1C(=O)C2(Cc3cn(C)c4ccccc34)SSC1(CO)C(=O)N2C56CC78SSC(CO)(N(C)C7=O)C(=O)N8C5Nc9ccccc69 DZRJLJPPUJADOO-UHFFFAOYSA-N 0.000 claims 1
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 claims 1
- 238000010276 construction Methods 0.000 claims 1
- 239000002537 cosmetic Substances 0.000 claims 1
- 125000000600 disaccharide group Chemical group 0.000 claims 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 claims 1
- 238000012377 drug delivery Methods 0.000 claims 1
- 229960002591 hydroxyproline Drugs 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 claims 1
- 230000029663 wound healing Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SG2013035977 | 2013-05-09 | ||
| SG201303597-7 | 2013-05-09 | ||
| PCT/SG2014/000204 WO2014182249A1 (en) | 2013-05-09 | 2014-05-09 | Modified collagen molecules |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016520585A JP2016520585A (ja) | 2016-07-14 |
| JP2016520585A5 true JP2016520585A5 (enExample) | 2017-06-15 |
Family
ID=51867585
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016512879A Pending JP2016520585A (ja) | 2013-05-09 | 2014-05-09 | 修飾コラーゲン分子 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20160075765A1 (enExample) |
| EP (1) | EP2994484A4 (enExample) |
| JP (1) | JP2016520585A (enExample) |
| CN (1) | CN105392799A (enExample) |
| SG (1) | SG11201509238WA (enExample) |
| WO (1) | WO2014182249A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL306070A (en) | 2018-05-03 | 2023-11-01 | Collplant Ltd | Dermal fillers and their uses |
| CN116410302B (zh) * | 2023-02-21 | 2025-09-12 | 汤臣倍健股份有限公司 | 一种富糖胺聚糖胶原蛋白肽的应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2672587B2 (ja) * | 1988-08-23 | 1997-11-05 | 生化学工業株式会社 | 新規ix型コラーゲン、それを構成する新規超高分子コンドロイチン硫酸及びそれらの製造法 |
| US5475052A (en) * | 1988-11-21 | 1995-12-12 | Collagen Corporation | Collagen-synthetic polymer matrices prepared using a multiple step reaction |
| US5866165A (en) * | 1997-01-15 | 1999-02-02 | Orquest, Inc. | Collagen-polysaccharide matrix for bone and cartilage repair |
| US6780841B2 (en) * | 2001-11-13 | 2004-08-24 | Biocell Technology, Llc | Hyaluronic acid and chondroitin sulfate based hydrolyzed collagen type II and method of making same |
| US20060067959A1 (en) * | 2004-09-28 | 2006-03-30 | Marcel Nimni | Compositions and methods for treatment of solar damage |
| US8283414B2 (en) * | 2004-11-23 | 2012-10-09 | The Johns Hopkins University | Compositions comprising modified collagen and uses therefor |
| CA2695288A1 (en) * | 2007-08-01 | 2009-02-05 | Ethicon, Inc. | Collagen-related peptides and uses thereof |
| US20090068250A1 (en) * | 2007-09-07 | 2009-03-12 | Philippe Gravagna | Bioresorbable and biocompatible compounds for surgical use |
| US20120122791A1 (en) * | 2009-05-01 | 2012-05-17 | Jnc Corporation | Substrate for cartilage cultivation using artificial collagen, and method for cartilage regeneration treatment using the substrate |
| PL2714718T3 (pl) * | 2011-05-24 | 2017-11-30 | Symic Ip, Llc | Syntetyczne peptydoglikany wiążące kwas hialuronowy, otrzymywanie i sposoby zastosowania |
| WO2013023137A2 (en) * | 2011-08-10 | 2013-02-14 | William Marsh Rice University | Multi-hierarchical self-assembly of a collagen mimetic peptide |
| JP6051619B2 (ja) * | 2012-06-29 | 2016-12-27 | Jnc株式会社 | コラーゲン様ポリペプチドの製造方法 |
-
2014
- 2014-05-09 SG SG11201509238WA patent/SG11201509238WA/en unknown
- 2014-05-09 EP EP14795215.4A patent/EP2994484A4/en not_active Withdrawn
- 2014-05-09 US US14/890,037 patent/US20160075765A1/en not_active Abandoned
- 2014-05-09 CN CN201480037498.7A patent/CN105392799A/zh active Pending
- 2014-05-09 WO PCT/SG2014/000204 patent/WO2014182249A1/en not_active Ceased
- 2014-05-09 JP JP2016512879A patent/JP2016520585A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1206297A1 (en) | Pharmaceutical compositions for combination therapy | |
| CY1122189T1 (el) | Ιονικες υδατικες συνθεσεις | |
| WO2017087608A8 (en) | Modulators of ror-gamma | |
| CY1119660T1 (el) | Antibakthpiakh απο toy στοματος συνθεση | |
| BRPI0912411B8 (pt) | uso de uma muteína de interleucina humana-2 (muteína de hil-2) e composição farmacêutica para o tratamento e/ou profilaxia de uma doença autoimune | |
| EP2540284A3 (en) | Compositions and methods for stabilized polysaccaride formulations | |
| JP2010215657A5 (enExample) | ||
| CY1117326T1 (el) | Παραγωγο κατεχολαμινης χρησιμο για τη θεραπεια ασθενειας parkinson | |
| BR112014021498A2 (pt) | composto, composição e método para tratar uma doença associada com formação de dna circular covalentemente fechado | |
| BRPI0915084A2 (pt) | composto, processo para a preparação de um composto, composição farmacêutica, uso de um composto, métodos para a profilaxia ou tratamento de um estado de doença ou uma condição e de câncer | |
| FI2034956T4 (fi) | Matalan viskositeetin omaavia glykosaminoglykaaneja käsittäviä koostumuksia ja mainitun koostumuksen käyttö kroonisen kystiitin terapiassa | |
| UA111588C2 (uk) | Композиція інгібітора jak для місцевого застосування | |
| MX2009008531A (es) | Cetonas de heterociclilo que contienen nitrogeno y su uso como inhibidores de c-met. | |
| MX2010004240A (es) | Derivados de oligosacaridos sulfatados novedosos. | |
| EA201391486A1 (ru) | Способы и композиции для лечения болезни паркинсона | |
| MY149505A (en) | Hyaluronic acid binary mixtures and therapeutic use thereof | |
| EP3059253A3 (en) | A sulphated polysaccharide compound for the clinical use and the preparation and use thereof | |
| WO2017062468A8 (en) | Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereof | |
| CY1117504T1 (el) | Παραγωγα 1-βενζυλ-3-υδροξυμεθυλινδαζολης και η χρηση τους στη θεραπευτικη αντιμετωπιση νοσων που βασιζονται στην εκφραση των mcp-1, και cx3cr1 | |
| CY1115734T1 (el) | Συνθεσεις benzenesulfonamide, μεθοδος συνθεσης τους, και χρηση αυτων στην ιατρικη | |
| BRPI0816798A2 (pt) | composto, composição farmacêutica, métodos para inibir a ação do glicogênio sintase cinase-3, e para tratar, prevenir ou melhorar uma doença, uso de um composto, e, artigo de fabricação | |
| MX2019009711A (es) | Mejoras en o con respecto a compuestos organicos. | |
| ATE530188T1 (de) | Zusammensetzungen und verfahren zur abgabe von mitteln gegen krebs | |
| FR2954945B1 (fr) | Composition cosmetique ou dermatologique, procede de traitement cosmetique et derive d'acide hyaluronique | |
| FR2978665B1 (fr) | Composition antiseptique |